About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, July 30th, 2015

The QualityStocks
Daily Stock List


Ekso Bionics Holdings, Inc. (EKSO)

Investing Daily, Total Wealth, Money Morning, PennyStocks24, Pennybuster, and TopStockAnalysts reported recently on Ekso Bionics Holdings, Inc. (EKSO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ekso Bionics Holdings, Inc. designs, develops, and commercializes exoskeletons, or wearable robots. Exoskeletons are ready-to-wear, battery-powered robots. They are strapped over the user's clothing, enabling individuals to achieve mobility, strength, or endurance not otherwise possible. These have a variety of potential applications in the medical, military, industrial, and consumer markets. The Company’s lead product is Ekso™. Ekso™ has helped thousands of people living with paralysis take millions of steps not otherwise possible. Ekso Bionics Holdings is based in Richmond, California.

The Company’s Ekso™ is a robotic exoskeleton used for the rehabilitation of individuals with lower extremity weakness, paralysis or hemiparesis (weakness on one side of the body) owing to such neurological conditions as stroke, spinal cord injury or disease, and traumatic brain injury. Ekso™ is a wearable bionic suit.

Ekso™ enables individuals with any amount of lower extremity weakness to stand up and walk over ground with a natural, full weight bearing, and reciprocal gait. Walking is attained through the user’s weight shifts to activate sensors in the device, which initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function.

Ekso Bionics Holdings has been accepted by the Center for Sensorimotor Neural Engineering (CSNE) as an industry partner. Ekso Bionics and CSNE are working jointly to enrich the human machine interface and enhance potential neural interface to create links between the nervous system and the outside world.  

Ekso Bionics has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH). This is to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland. This work will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton.

Ekso GT™ with SmartAssist™ features include the next generation of adaptive assistance software, allowing a greater number of interactive steps; PreGait, a group of early mobilization activities for pre-ambulatory patients preparing for gait therapy; and FreeGait, an advanced mode for patients progressing to community ambulation.

Ekso Bionics announced in January 2015 that nine leading centers in Europe including SPZ Notwill in Switzerland, Institut Guttmann in Spain, and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark (now part of Rigshospitalet and Glostrup Hospital), are participating in a clinical study to include around 70 participants.

The study will examine how Ekso GT may improve general outcomes and reduce secondary complications, including pain and bowel and bladder dysfunction, normally associated with spinal cord injury (SCI). The expectation is that the study will run for 30 months with early findings expected next year.

Ekso Bionics Holdings, Inc. (EKSO), closed Thursday's trading session at $1.03, down 2.83%, on 152,519 volume with 225 trades. The average volume for the last 60 days is 901,478 and the stock's 52-week low/high is $0.753/$2.34.

Omagine, Inc. (OMAG)

BUYINS.NET, PennyStocks24, Information Solutions Group, Agoracom, SmallCapVoice, and OnTheMar reported on Omagine, Inc. (OMAG), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Omagine, Inc. conducts all of its real-estate development, tourism, and entertainment business activities through either its 60 percent owned subsidiary Omagine LLC or its 100 percent owned subsidiary Journey of Light, Inc. Omagine’s focus is on real-estate, entertainment, and hospitality opportunities in the Middle East and North Africa (MENA Region). Omagine is headquartered in New York City.

The Company’s projects always include traditionally designed residential and commercial components. Nevertheless, the tourism components are thematically instilled with culturally aware and scientifically accurate entertainment experiences. All of Omagine’s developments are historically faithful to their surroundings.

Omagine has a family-oriented design and development predisposition. It utilizes this to make its properties tell true and entertaining stories about their surroundings and the world. Omagine’s developments seamlessly integrate entertainment with art, culture, science, and history.

Omagine announced in October of 2014 that Omagine LLC signed a Development Agreement (DA) with the Government of the Sultanate of Oman. Omagine organized Omagine LLC under the laws of Oman to design, develop, own, and operate a tourism and real-estate development project in Oman called the Omagine Project.

Omagine LLC owns the Omagine Project. The other Omagine LLC shareholders are the office of Royal Court Affairs (RCA), which owns 25 percent, and two subsidiaries of Consolidated Contractors International Company, SAL (CCIC), which collectively own 15 percent.

Omagine chooses unique locations, mainly in the MENA Region, which it designs and develops into distinctive tourism destinations. Currently, Omagine focuses the majority of its efforts on the business of Omagine LLC and specifically on the Omagine Project.

The Omagine Project is planned to be an elegant integration of cultural, scientific, heritage, entertainment and residential components. This includes a high culture theme park containing seven pearl shaped (20 meter diameter) buildings (the Pearls) situated along an open air boardwalk with associated entertaining exhibitions; an amphitheater and stage; open space green landscaped areas; a canal; and an enclosed harbor and marina.

The Project also includes boat slips and docking facilities; retail shops; an array of restaurants and cafes; entertainment venues; a five-star resort hotel; a four-star hotel; and possibly an additional three or four-star hotel; shopping and retail establishments integrated with the hotels; commercial office buildings; and over 2000 residences to be developed for sale by Omagine LLC.

Earlier this month, Omagine announced that its subsidiary, Omagine LLC, signed and registered with the Government of Oman, a Usufruct Agreement (UA) that legally perfects Omagine's ownership of the development rights (the Usufruct Rights) over 245 acres of beachfront land in the Sultanate of Oman.

Omagine, Inc. (OMAG), closed Thursday's trading session at $2.30, down 6.12%, on 156 volume with 2 trades. The average volume for the last 60 days is 9,040 and the stock's 52-week low/high is $1.20/$3.94.

BioSig Technologies, Inc. (BSGM)

Pumps and Dumps, Stockgoodies, SizzlingStockPicks, WallstreetSurfers, PennyStock Tweets, and SECFilings.com News reported on BioSig Technologies, Inc. (BSGM), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

BioSig Technologies, Inc. is a medical device company that lists on the OTC Markets Group’s OTCQB.  The Company is developing PURE EP™, which is a proprietary technology platform designed to improve the clinical outcomes of electrophysiology (EP) procedures. Its’ objective is to seek Food and Drug Administration (FDA) 510(k) approval for the PURE EP™ System. BioSig is preparing to commercialize the PURE EP™ System. BioSig Technologies is based in Minneapolis, Minnesota and it also maintains an office in Los Angeles, California dedicated to research and development (R&D).

BioSig’s PURE EP™ is a next-generation surface electrocardiogram and intracardiac multichannel recording and analysis system. The design of it is to help electrophysiologists in making clinical decisions in real-time through acquiring and displaying high-fidelity cardiac signal recordings and providing guidance in identifying ablation targets (areas of tissue to destroy that otherwise create a heart rhythm disturbance or arrhythmia).

BioSig Technologies has achieved proof of concept validation through UCLA EP & Animal Labs. It is collaborating with a number of the nation's most prestigious cardiac arrhythmia centers. These include Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, and the Mayo Clinic.

Recently, BioSig Technologies announced that it appointed Mr. David Weild to the Board of Directors. Mr. Weild has been elected to Chair the Audit Committee of the Board as BioSig prepares to uplist to a National Stock Exchange. Mr. Weild brings extensive financial, economic, stock exchange, capital markets, and small company expertise to BioSig Technologies attained through his successful career on Wall Street.

Yesterday, BioSig Technologies announced it signed a Sponsored Research Agreement with The Regents of The University of California at Los Angeles (UCLA) to conduct preclinical evaluation of the Company’s PURE EP™ System in a ventricular tachycardia (VT) model. The studies will focus on intracardiac and percutaneous epicardial mapping employing the PURE EP information system to explore the complex scar architecture that normally supports multiple morphologies of VT.

BioSig Technologies, Inc. (BSGM), closed Thursday's trading session at $1.70, down 5.56%, on 14,600 volume with 7 trades. The average volume for the last 60 days is 18,746 and the stock's 52-week low/high is $1.31/$4.80.

Genius Brands International, Inc. (GNUS)

RedChip reported on Genius Brands International, Inc. (GNUS), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed Genius Brands International, Inc. is an international brand management company. It creates and licenses multimedia content for toddlers to tweens. Genius Brands creates "content with a purpose". This means content that is as entertaining as it is enriching. A Squared Entertainment is a wholly-owned subsidiary of Genius Brands International. Genius Brands’ A Squared Entertainment is a brand management and licensing company. Genius Brands is headquartered in Beverly Hills, California.

The Company’s growing library of content includes the award-winning Baby Genius, Warren Buffett's Secret Millionaires Club, Thomas Edison's Secret Lab, and Llama Llama, from the New York Times bestselling children's book franchise, and Stan Lee's Mighty 7, the first project from Stan Lee Comics, a joint venture with Stan Lee's POW! Entertainment.

The Company’s A Squared Entertainment represents third-party properties across a broad assortment of categories in territories around the world. A Squared Entertainment currently represents Psycho Bunny, a luxury apparel line; From Frank, a humor greeting card and product line; and Celessence Technologies, the world's top microencapsulation company.

Genius Brands International announced has licensed its original animated series Thomas Edison's Secret Lab to the premiere broadcast channel Da Vinci Learning for airing in Russia, Central and Eastern Europe, Turkey, and Africa. An academic team headed by Professor Emeritus, Don Roberts, and a team of Emmy Award winning writers developed Thomas Edison's Secret Lab. This ensures it’s E/I (Educational/Informational) compliant per FCC standards. Thomas Edison's Secret Lab is a fully immersive multimedia property. It encourages children to engage themselves in the fun and exploration of science.

Genius Brands International has awarded Wicked Cool Toys the exclusive global rights to develop and market a broad line of toys based on Genius Brands' original animated adventure series, Thomas Edison's Secret Lab. This is the aforementioned new comedy that shows kids how much fun science can be. Wicked Cool will develop and bring to market an appealing line of STEM-based toys. These include compounds, activity kits, science kits, food sets, figures, play sets, novelties and role play products.

This week, Genius Brands International announced that it and its wholly owned subsidiary, A Squared Entertainment, signed two additional top-tier licensees for the luxury fashion apparel and lifestyle brand Psycho Bunny. Timepiece distributor Zeon America and Idea House, which designs, develops, sells and markets products across a portfolio of owned and licensed brands including CURATED Idea Merchants Unlimited, join the increasing list of licensees developing a coordinated range of product lines under the Psycho Bunny brand.

Genius Brands International, Inc. (GNUS), closed Thursday's trading session at $2.25, up 2.27%, on 21,954 volume with 32 trades. The average volume for the last 60 days is 6,309 and the stock's 52-week low/high is $1.33/$3.35.

Cannabis Sativa, Inc. (CBDS)

Greenbackers, TheMicrocapNews, TopStockAnalysts, Flagler Financial Group, smartOTC, and Real Pennies reported previously on Cannabis Sativa, Inc. (CBDS), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

OTC Bulletin Board-listed Cannabis Sativa, Inc. engages in branding and licensing through its 'hi' intellectual properties. The Company is engaged via its subsidiary, KUSH, in the research, development and licensing of specialized natural cannabis products. This includes cannabis formulas, edibles, topicals, strains, recipes, as well as delivery systems. Cannabis Sativa is headquartered in Mesquite, Nevada.

The Company also has its Wild Earth Naturals, Inc. subsidiary. This subsidiary develops, manufactures, distributes, and sells herbal based skin care products in the United States and around the world. Wild Earth Naturals offers an herbal based line of products.

Cannabis Sativa brands, licenses, innovates, and markets first-class plant-derived topical creams, transdermals, balms, sublinguals, lubricants, and edibles for medical and recreational marijuana consumers, and also legal nutraceuticals and branded merchandise for consumers in general. Its plan is to license the "hi" brand to distributors and producers of quality products and to other ancillary participants in the retail cannabis industry.

Cannabis Sativa announced earlier this year that its wholly-owned subsidiary, Hi Brands International, Inc., entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products. Cannabis Sativa’s plan is to market their CBD capsules under the name, "hi CBD." Each capsule contains 7.5 mg of water-soluble CBD and sells in bottles of 60 capsules, which constitutes the recommended monthly usage of two capsules daily.

Last week, Cannabis Sativa management clarified what the spin-off of KUSH means for the Company’s (CBDS’) shareholders: "In summary, all CBDS shareholders will receive KUSH shares in addition to the CBDS shares they already own," stated Cannabis Sativa Chief Executive Officer, Mr. Gary Johnson. "It is anticipated at this time that each current shareholder of CBDS will receive as a dividend on its CBDS common stock, approximately four shares of KUSH (the Public KUSH Stock) for each share of CBDS stock held on the Record Date."

KUSH will become a free standing public company. Its common shares will be quoted on the OTC Markets’ OTCQB. Nine percent of Kush will be retained by CBDS. CBDS will take direct possession of the assets CBDS presently has by way of agreements with KUSH and KPAL.

Cannabis Sativa, Inc. (CBDS), closed Thursday's trading session at $1.95, down 3.47%, on 25,749 volume with 29 trades. The average volume for the last 60 days is 11,252 and the stock's 52-week low/high is $1.80/$11.00.


The QualityStocks
Company Corner


On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $1.83, up 57.76%, on 186,163 volume with 328 trades. The stock’s average daily volume over the past 60 days is 22,803, and its 52-week low/high is $0.2501/$11.04.

On the Move Systems, Inc.: As development work continues for the company's “Uber for Trucking” portal, OMVS has focused its sights on mid-market haulers as the best potential users of the revolutionary shared economy online app. Firms in this range often lack sophisticated transport management systems (TMS) to administer efficiently ever more complicated freight networks. A recent survey conducted by Logistics Management revealed that only 35 percent of shippers, including truckers, are using TMS in their daily businesses. That usage figure drops even lower when broken down by company size, Logistics Management said, with mid-size and small-size shippers having the lowest TMS adoption rates.

On the Move Systems, Inc. (OMVS) specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a premier group of international providers to offer its services in two key divisions: Trucking Logistics and Inter-modal Freight.

Logistics are critical to the success of any operation. OMVS's Trucking Logistics division operates as one of the most competitive, full-service transportation logistics providers in the United States. Utilizing the company's ISTx Platform, this division helps customers strategize how to get from one point to another, as well as solves some of the toughest logistics challenges on the road today. OMVS's Trucking Logistics technology provides customers increased visibility, minimal-cost route effectiveness, and delivery assurance.

OMVS's Intermodal Freight division offers seamless cargo continuation, tracking, shipping and receiving of goods anywhere in the world. The company's customer service teams and drivers communicate through the ISTx Platform allowing for flexibility, control and monitoring of each freight shipment. OMVS continues to research and explore the most effective and resourceful tools in order to effectively serve customers with unique shipping requirements in the billion dollar trucking industry.

In his more than 20 years of experience, OMVS president and CEO Robert Wilson has cultivated vast expertise as an executive and financial consultant for companies in aviation, energy, oil and gas, IT and healthcare. In addition to his work valuing and assessing small-to-middle market companies, Wilson has also served as both an officer and director of such client companies. Wilson applies his expertise in the transportation business and investment banking to spearhead OMVS's new initiative to create a new kind of online transportation platform to an international market Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS: Mid-Market Shippers Good Fit for Upcoming On-Demand Trucking Market

OMVS Finding Strong Market Potential for Shared Economy Courier Service

OMVS: Shared Economy Courier Service Offers Great Market Potential

Fastfunds Financial Corp. (FFFC)

The QualityStocks Daily Newsletter would like to spotlight Fastfunds Financial Corp. (FFFC). Today, Fastfunds Financial Corp. closed trading at $0.0004, on 34,982,722 volume with 77 trades. The stock’s average daily volume over the past 60 days is 10,343,544, and its 52-week low/high is $0.0004/$0.24.

Fastfunds Financial Corp. announced today that it has signed Casa Giallo, Inc. (CG) as the exclusive creative agency for the Tommy Chong Green Card (TCGC). CG will provide traditional and social media strategy as well as be responsible for managing and executing all marketing, branding and advertising efforts pertaining to TCGC. We chose Casa Giallo due to their capabilities in every phase of creative, said Kurt Martig, President of FFFC subsidiary, Cannabis Merchant Financial Solutions. They combine breadth of advertising experience with cannabis industry intelligence in a way that will help set us apart in the marketplace.

Fastfunds Financial Corp. (FFFC) operates through two wholly owned subsidiaries, Cannabis Angel, Inc. and The 420 Development Corporation, to build a portfolio of revenue-generating companies that provide ancillary services to the burgeoning cannabis industry. The company also operates majority-owned subsidiary Financiera Moderna, Inc., which offers financial services to the underserved Hispanic community. FFFC's strategy to participate in the marijuana industry is through the development of four separate business verticals for the emerging U.S. cannabis industry.

Through its 49% stake in Cannabis Merchant Financial Solutions, Inc. (CMFS), FFFC entered the Financial Service business vertical. CMFS developed the Green Card and Tommy Chong Green Card, a reloadable stored value card with a rewards feature, and the Tommy Chong Frequent Buyers Card, which functions as a gift card or rewards card. FFFC is developing a national group of master resellers, distributors and sales representatives for these card products.

As the cannabis industry continues to develop, FFFC is partaking in Plant Botany, specifically the development of methods and technologies to significantly enhance plant growth and purity. Under an operating agreement with Sanidor Systems to create Pure Grow Systems, LLC, FFFC acquired a 49% interest in the subsidiary, which is dedicated to the healthy production and processing of raw materials used for medicinal or other health related purposes.

The cannabis industry is a cash-only business, which leaves companies vulnerable to criminal activities. FFFC plans to address this issue and enter the Security Services and Equipment sector through the acquisition of an existing, operational security company. FFFC owns a 70% stake in Ohio-based Brawnstone Security, Inc., a diversified security, training and investigations company. FFFC's research shows that operating margins for cannabis-related security services could exceed current billing levels by at least 100%.

FFFC's Cannabis Angel, Inc. ("CA") subsidiary will evaluate and provide corporate development services and early seed financing for worthwhile development-stage cannabis ventures. To date, CA has made investments in companies involved in the distribution of cannabis-related products and development of a social media website. It is important to note that all of FFFCs activities in the cannabis industry are ancillary, or pick and shovel, and are evaluated to insure compliance with all state and federal Laws. Disclaimer

Fastfunds Financial Corp. Company Blog

Fastfunds Financial Corp. News:

Fastfunds Financial Corporation Announces Casa Giallo to Be Creative Agency for Tommy Chong Green Card

FastFunds Financial Corporation Subsidiary Pure Grow Systems, LLC Signs Distribution Agreement

Fastfunds Financial Corporation Announces 20 Year Veteran In Managing High Profile Celebrities And Brands Named As Brand And Marketing Specialist For Tommy Chong Green Card

WRIT Media Group, Inc. (WRITD)

The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRITD). Today, WRIT Media Group, Inc. closed trading at $0.72, up 94.59%, on 2,725 volume with 2 trades. The stock’s average daily volume over the past 60 days is 8,725, and its 52-week low/high is $0.20/$16.00.

WRIT Media Group, Inc. (WRITD) is focused on expanding in the digital media industry. The holding company currently operates under two different divisions: content creation via Front Row Networks, and "retro" video gaming via Retro Infinity Inc. and Amiga Games Inc.

The company’s Front Row Networks subsidiary produces, acquires and distributes live concerts in 2D and 3D format for initial worldwide digital broadcast into digitally-enabled movie theaters. In addition to presenting live concerts to massive audiences at lower ticket prices, Front Row Networks will license the content for many different distribution channels and sell merchandize where the live concerts are exhibited. The subsidiary also secures and distributes non-concert alternative theatrical programming and aims to acquire the broadest range of rights for exclusive programming.

Retro Infinity specializes in licensing classic computer and console video game libraries and adapts and republishes the most popular titles for smartphones, modern game consoles, micro-consoles, PCs, and tablets. The company leverages platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.

Amiga Games Inc. shares resources with Retro Infinity to adapt and republish the most popular titles from the Amiga family of computers for smartphones, modern game consoles, micro-consoles, PCs, and tablets. WRIT Media Group leverages the Amiga brand along with game brands of the past and proprietary technologies to create new revenue from classic games that have proven their ability to sell very well.

Together with its subsidiaries, WRIT Media Group is well positioned to benefit from the market growth and increased demand for alternative theatrical, mobile, and interactive content. Disclaimer

WRIT Media Group, Inc. Company Blog

WRIT Media Group, Inc. News:

WRIT Media Group Featured in Exclusive QualityStocks Production Video

Retro Infinity Announces Remaining 2014 NASCAR Nationwide Championship Series Events

WRIT Media Group Announces Product Updates and NASCAR Event Recap

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.04, up 14.29%, on 5,100 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,411, and its 52-week low/high is $0.03/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President

International Stem Cell Corp. (ISCOD)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCOD). Today, International Stem Cell Corp. closed trading at $4.40, off by 16.98%, on 16,568 volume with 131 trades. The stock’s average daily volume over the past 60 days is 14,644, and its 52-week low/high is $5.25/$19.20.

International Stem Cell Corp. (ISCOD) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces 1:150 Reverse Stock Split

International Stem Cell Corporation to Present at International Society for Cellular Therapy Annual Meeting

International Stem Cell Corporation Announces 2015 First Quarter Results


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Wall Street Resources



By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251